Enzyme, Selenoprotein, Antioxidant enzyme, Glutathione peroxidase family member
01
Overview
Glutathione peroxidase 2 is a selenium-dependent enzyme predominantly expressed in the epithelial cells of the gastrointestinal tract (and in the liver in humans). It reduces hydrogen peroxide and organic hydroperoxides to less reactive molecules using glutathione, thereby protecting cells against oxidative damage and maintaining redox balance. GPX2 is transcriptionally regulated by the Wnt and Nrf2 pathways and plays a critical role in mucosal homeostasis, limiting inflammation, and supporting cell differentiation and proliferation in crypt cells. It is implicated as a protective factor in early tumorigenesis but may also support the growth of established tumors, resulting in complex "Janus-faced" roles in cancer biology. GPX2-deficient animals show heightened sensitivity to oxidative stress and inflammation. While no drugs selectively target GPX2, its activity is sensitive to selenium levels and could serve as a biomarker for diseases of oxidative stress or gut inflammation.
If hypothetically targeted: inhibition or upregulation would modulate cellular redox state, apoptosis, inflammation, and cancer cell proliferation
03
Biological functions
Catalyzes reduction of hydrogen peroxide and organic hydroperoxides using glutathioneProtects cells from oxidative damageMaintains redox balance in gastrointestinal tissueLimits apoptosis and regulates cell proliferation/differentiation in crypt cellsModulates Wnt signaling pathway for stem cell maintenance and epithelial homeostasisPrevents inflammation in the gastrointestinal tract
04
Disease associations
Cancer (especially colorectal, and modulates tumor biology in the gut)Inflammation (deficiency results in increased susceptibility to inflammatory ileocolitis)Other (roles in maintaining mucosal homeostasis)
05
Safety considerations
Therapeutic modulation could disrupt redox balance, increasing oxidative stress, cell death, or inflammationOverexpression in the context of tumors may promote tumor growth and cell survival, presenting oncogenic risksSelenium toxicity if given excessively to upregulate selenoproteins (general risk, not GPX2-specific)
06
Interacting drugs
No clinically approved drugs selectively target GPX2 as of current literature.
1 more in the full profile.
07
Biomarkers
GPX2 expression in tumor tissue can indicate prognosis in colorectal cancer or cancer cell differentiation statusReduced GPX2 expression may serve as a biomarker for increased inflammatory risk and mucosal damage
Beyond the preview
Go deeper on Glutathione peroxidase 2 (GPX2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glutathione peroxidase 2 (GPX2).